Neostigmine HHH neostigmine methylsulfate 2.5 mg/1 ml solution for injection ampoule
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
26-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
neostigmine methylsulfate
Available from:
Juno Pharmaceuticals Pty Ltd
INN (International Name):
neostigmine methylsulfate
Authorization status:
Registered
